MR-Guideline? [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2010-04-23 14:34 (5893 d 00:09 ago) – Posting: # 5197
Views: 26,417

Dear Marcel!

You did not dig deep enough. At the end of the table on page 60 it is stated:
CPMP/EWP/280/96 – Note for guidance on Modified Release Oral and Transdermal Dosage Forms: Section II – Revision to be considered

❝ If this is still the case, in your opinion can we expect a draft guidance out in 2010?


Don’t know. I’m not optimistic for a draft that early. As an example: regulators talked at conferences about a revision of the (IR)BE-GL in mid-2004, the Q&A was published as some kind of ‘intermediate’ in 2006, the ‘Recommendation on the Need for Revision of NfG on BA/BE’ in 2007, and the draft in 2008…

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
135 visitors (0 registered, 135 guests [including 21 identified bots]).
Forum time: 14:43 CEST (Europe/Vienna)

There are no dangerous thoughts;
thinking itself is dangerous.    Hannah Arendt

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5